Found: 5
Select item for more details and to access through your institution.
Response to apatinib and camrelizumab combined treatment in a radioiodine refractory differentiated thyroid cancer patient resistant to prior anti-angiogenic therapy: A case report and literature review.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.943916
- By:
- Publication type:
- Article
Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer.
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2024.1354426
- By:
- Publication type:
- Article
Characterizing Genetic Alterations Related to Radioiodine Avidity in Metastatic Thyroid Cancer.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 5, p. 1231, doi. 10.1210/clinem/dgad697
- By:
- Publication type:
- Article
Fusion Oncogenes in Patients With Locally Advanced or Distant Metastatic Differentiated Thyroid Cancer.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 2, p. 505, doi. 10.1210/clinem/dgad500
- By:
- Publication type:
- Article
Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene DAB2 as a Prognostic Biomarker in Differentiated Thyroid Carcinoma.
- Published in:
- Disease Markers, 2022, p. 1, doi. 10.1155/2022/1686316
- By:
- Publication type:
- Article